Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Cardinaels (Leuven, Belgium), Y. Vande Weygaerde (Ghent, Belgium), P. Bomans (Antwerpen, Belgium), T. Chin (Ghent, Belgium), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium). Adherence to NTM treatment guidelines in three reference centers in Belgium. 2934

Member's Comments

No comment yet.

Related content which might interest you: Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Are TB services in England adhering to new NICE guidelines on screening for latent TB? Source: International Congress 2017 – Migrants and screening Year: 2017 Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 The new ATS and ERS TB treatment guidelines Source: International Congress 2016 – ERS and tuberculosis Year: 2016 Community acquired pneumonia in Greece: clinical, laboratory data – adherence to the international guidelines Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016 Developing standards for TB and MDR-TB management in the European Union setting Source: Annual Congress 2010 - Multidrug-resistant tuberculosis and novel influenza: back to the future - "Lessons learnt from two respiratory emergencies" Year: 2010 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Community acquired pneumonia in Greece: Clinical, microbiological data and adherence to the IDSA guidelines Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Recommended standards for modern tuberculosis laboratory services in Europe Source: Eur Respir J 2006; 28: 903-909 Year: 2006 Active case-finding of tuberculosis in Europe Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007 Tuberculosis: cost of illness in Germany Source: Eur Respir J 2012; 40: 143-151 Year: 2012 The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines? Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Local antibiotic guidelines for management of adult community acquired pneumonia in UK hospitals Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 The implementation of IDSA/ATS and the Greek national guidelines for CAP by chest physicians in Greece Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Community acquired pneumonia guidelines: not only treatment indications Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 Adherence to GOLD guidelines practices in the management of COPD in  Tunisia Source: International Congress 2018 – COPD around the world Year: 2018